Trademarks = 1

Forward Citations = 0

Loading Chart...

16 inventors (with patents filed for the assignee):

Xiaoqiang Yan (4 out of 29 patents)

Yumin Cui (1 out of 12 patents)

Zhihua Huang (1 out of 9 patents)

4. Marcel Van Den Brink (1 out of 9 patents)

5. Jay Kennedy Kolls (1 out of 5 patents)

6. Dongdong Wu (1 out of 3 patents)

7. Kaiyang Tang (1 out of 2 patents)

8. Yuliang Huang (1 out of 8 patents)

9. Alan Hanash (1 out of 3 patents)

10. Tom Tang (1 out of 2 patents)

11. Misty Lynn Good (1 out of 1 patent)

12. Caroline Lindemans (1 out of 1 patent)

13. Cheng Yi Huang (1 out of 37 patents)

14. William Daley (1 out of 1 patent)

15. Wuzhong Shen (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12577305 - MULTISPECIFIC ANTIGEN BINDING PROTEINS CAPABLE OF BINDING CD19 AND CD3, AND USE THEREOF (2026-03-17),

2. 12527875 - METHODS FOR TREATING GRAFT VERSUS HOST DISEASE (2026-01-20),

3. 11654104 - Use of IL-22 dimer in manufacture of a medicament for intravenous administration (2023-05-23),

4. 11564973 - Methods of use for IL-22 in the treatment of gastrointestinal graft vs. host disease (2023-01-31),

5. 11510966 - Use of IL-22 in treating necrotizing enterocolitis (2022-11-29),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#455 in Shanghai

#5,255 in China

Shanghai, China

Evive Biotechnology (Shanghai) Ltd

Forward Citations = 0

16 inventors:

Xiaoqiang Yan (4 out of 29 patents)

Yumin Cui (1 out of 12 patents)

Zhihua Huang (1 out of 9 patents)

4. Marcel Van Den Brink (1 out of 9 patents)

5. Jay Kennedy Kolls (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Evive Biotechnology (Shanghai) Ltd. Retrieved from https://idiyas.com/company/evive-biotechnology-shanghai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]